Want to buy a stock? Check the related industry trend and it's relative strength. Enter a stock ticker here:

Don’t fight the industry trends – ride them!

Register for free alerts

 


Sector Trends Service: which vehicle to choose?


Useful links

Narrow your search and focus on stocks with strongest bullish (or bearish) signals.
In the first two tables tickers are sorted according to their rating.

Biotechnology: best performers


For bullish play focus on tickers with maximum number of green stars. Buy full access to our PDF reports with in-depth analysis.

Our Rating

Capitalization

Closing price

LONG-TERM

SHORT-TERM

Outlook

Relative Strength

Outlook

Relative Strength

CRL

Buy

1.50B

65.2 (1.63)

CRL long-term outlook: bullish

CRL long-term strength in the Biotechnology industry: underperform

CRL short-term outlook: bullish

CRL short-term strength in the Biotechnology industry: outperform

HGSI

Buy

1.66B

10.77 (0.26)

HGSI long-term outlook: bullish

HGSI long-term strength in the Biotechnology industry: underperform

HGSI short-term outlook: bullish

HGSI short-term strength in the Biotechnology industry: outperform

IVGN

Buy

1.92B

95.71 (2.44)

IVGN long-term outlook: bullish

IVGN long-term strength in the Biotechnology industry: underperform

IVGN short-term outlook: bullish

IVGN short-term strength in the Biotechnology industry: outperform

AFFX

Neutral

1.24B

22.6 (0.41)

AFFX long-term outlook: bearish

AFFX long-term strength in the Biotechnology industry: outperform

AFFX short-term outlook: neutral

AFFX short-term strength in the Biotechnology industry: underperform

ALKS

Neutral

700.70M

15.17 (0.18)

ALKS long-term outlook: very bearish

ALKS long-term strength in the Biotechnology industry: outperform

ALKS short-term outlook: bullish

ALKS short-term strength in the Biotechnology industry: underperform


Biotechnology: worst performers


For bearish play focus on tickers with maximum number of red stars. Buy full access to our PDF reports with in-depth analysis.

Our Rating

Capitalization

Closing price

LONG-TERM

SHORT-TERM

Outlook

Relative Strength

Outlook

Relative Strength

AMGN

Sell

83.78B

49.45 (-0.59)

AMGN long-term outlook: bullish

AMGN long-term strength in the Biotechnology industry: underperform

AMGN short-term outlook: bearish

AMGN short-term strength in the Biotechnology industry: underperform

AMLN

Sell

2.02B

38.83 (0.33)

AMLN long-term outlook: very bearish

AMLN long-term strength in the Biotechnology industry: outperform

AMLN short-term outlook: bearish

AMLN short-term strength in the Biotechnology industry: underperform

DNA

Sell

37.91B

69.77 (-0.67)

DNA long-term outlook: very bearish

DNA long-term strength in the Biotechnology industry: outperform

DNA short-term outlook: bearish

DNA short-term strength in the Biotechnology industry: underperform

RX

Sell

4.37B

22.52 (-0.31)

RX long-term outlook: bearish

RX long-term strength in the Biotechnology industry: outperform

RX short-term outlook: bearish

RX short-term strength in the Biotechnology industry: underperform

ONXX

Sell

287.69M

55.06 (-1.35)

ONXX long-term outlook: bullish

ONXX long-term strength in the Biotechnology industry: underperform

ONXX short-term outlook: bearish

ONXX short-term strength in the Biotechnology industry: underperform


Biotechnology: maximum capitalization


Looking for robust companies? Here they are sorted according to their capitalization. Buy full access to our PDF reports with in-depth analysis.

Our Rating

Capitalization

closing price

LONG-TERM

SHORT-TERM

Outlook

Relative Strength

Outlook

Relative Strength

AMGN

Sell

83.78B

49.45 (-0.59)

AMGN long-term outlook: bullish

AMGN long-term strength in the Biotechnology industry: underperform

AMGN short-term outlook: bearish

AMGN short-term strength in the Biotechnology industry: underperform

DNA

Sell

37.91B

69.77 (-0.67)

DNA long-term outlook: very bearish

DNA long-term strength in the Biotechnology industry: outperform

DNA short-term outlook: bearish

DNA short-term strength in the Biotechnology industry: underperform

GILD

Neutral

10.75B

46.24 (-0.61)

GILD long-term outlook: very bullish

GILD long-term strength in the Biotechnology industry: underperform

GILD short-term outlook: bullish

GILD short-term strength in the Biotechnology industry: underperform

GENZ

Neutral

9.52B

73.79 (0.1)

GENZ long-term outlook: bullish

GENZ long-term strength in the Biotechnology industry: underperform

GENZ short-term outlook: bullish

GENZ short-term strength in the Biotechnology industry: underperform

DGX

Neutral

6.65B

53.91 (-0.16)

DGX long-term outlook: bullish

DGX long-term strength in the Biotechnology industry: outperform

DGX short-term outlook: bullish

DGX short-term strength in the Biotechnology industry: underperform

Click here to get performance analysis for this industry. It helps to identify best stocks to trade.

Buy unlimited one-week access to our comprehensive reports in PDF format for more details (sample).
Outlook estimates are based on MACD indicators.
Relative strength is calculated in the broader industry (or sector).


Our reports use comprehensive multi-level analysis with a sub-industry/industry/sector bottom-up approach. The Reports differ from traditional across-industries comparison reports that show the past performance only. We include the future trends based on a wide range of technical signals that were computed for related industries and sectors. By aggregating industries and computing all technicals we implicitly take into account and reveal the action of the big market players that have an influence on the market.

Technical and Industry Analysis Reports will help you avoid the 5 common mistakes made by traders:

* Betting on a weakening stock in the industry. You will see the relative strength of your stock and find out how it changes over time.

Open pages 3 - 4 and learn how your stock is strengthening (or weakening) against the related industry. Even more, find out how strong the industry is in its sector. Remember that the strength usually fluctuates. Do not ignore the strength changes.


* Ignoring the evidence that the market is showing you. The reports include an extensive set of technical indicators for daily and weekly charts. You won't miss anything.

Open page 5 and find at-a-glance all the most widely used technical indicators with the signals they generate. There is no need to analyze charts. It is already done.


* Fighting an industry trend. We will show you how the strength/weakness of the trend in a stock's related industry/sector.

Open pages 7-18 and look through all technicals for the related sub-industry, industry and sector. This "bottom-up" approach will help you to avoid very risky situations when you go against the industry trend. The "Big Boys" play the "industry rotation game", and you should be aware of it.


* Ignoring all other potential picks in the industry. You will see all technicals for other companies in the same industry and sub-industry. It will help you to double-check your choice and select another, more attractive pick if necessary.

Open pages 6 and 12 and find our Check Lists with the key technical for other stocks (trend setters, best and worst performers) in the related industry and sector.


* Incorrect chart interpretation. You don't need to waste you time to analyze the charts and yet get it wrong. OptionSmart gives you the true picture at-a-glance for you to make the right decision.

Useful links

 

   © www.stocksight.com | contact us. Updated: 12/13/07, 10:12 PM EST